Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
---|---|---|---|---|
Capital Group Central Cash Fund | Short Term | 882,095 | $88,209,471.00 | 4.78% |
U.S. Treasury 4.625% 5/15/2044 | Fixed Income | 41,666,000 | $41,586,530.00 | 2.25% |
U.S. Treasury 4.375% 5/15/2034 | Fixed Income | 30,917,000 | $30,929,113.00 | 1.68% |
U.S. Treasury 4.25% 6/30/2029 | Fixed Income | 30,474,000 | $30,335,915.00 | 1.64% |
AbbVie, Inc. 5.05% 3/15/2034 | Fixed Income | 26,701,000 | $26,633,019.00 | 1.44% |
Pfizer Investment Enterprises Pte., Ltd. 4.75% 5/19/2033 | Fixed Income | 24,631,000 | $24,009,954.00 | 1.3% |
U.S. Treasury 4.25% 2/15/2054 | Fixed Income | 18,745,300 | $17,857,253.00 | 0.97% |
JPMorgan Chase & Co. 5.581% 4/22/2030 (USD-SOFR + 1.16% on 4/22/2029) | Fixed Income | 16,330,000 | $16,592,423.00 | 0.9% |
Bristol-Myers Squibb Co. 5.20% 2/22/2034 | Fixed Income | 16,029,000 | $16,002,312.00 | 0.87% |
Boeing Co. 2.75% 2/1/2026 | Fixed Income | 16,088,000 | $15,295,521.00 | 0.83% |
ServiceNow, Inc. 1.40% 9/1/2030 | Fixed Income | 18,798,000 | $15,268,356.00 | 0.83% |
Cisco Systems, Inc. 5.05% 2/26/2034 | Fixed Income | 14,836,000 | $14,830,540.00 | 0.8% |
Morgan Stanley 5.831% 4/19/2035 (USD-SOFR + 1.58% on 4/19/2034) | Fixed Income | 13,278,000 | $13,616,005.00 | 0.74% |
BP Capital Markets America, Inc. 4.893% 9/11/2033 | Fixed Income | 13,489,000 | $13,123,300.00 | 0.71% |
Johnson & Johnson 4.95% 6/1/2034 | Fixed Income | 12,905,000 | $13,060,221.00 | 0.71% |